home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Slimming Drug Explained

 
  September, 9 2003 8:10
your information resource in human molecular genetics
 
     
Scientists are beginning to understand how OEA, a naturally occurring compound that stops mice from overeating, has its effects. Research in Nature (Vol. 425, No. 6953, dated 4 September 2003, pp. 90-93) reveals that the molecule binds to a receptor known as PPAR-alpha. Molecules designed to target this receptor may prove to be effective treatments for eating disorders.

OEA, or oleylethanolamide, is known to regulate feelings of 'fullness' and body weight. Daniele Piomelli and colleagues show that the molecule binds to the nuclear protein, mimicking the action of other synthetic PPAR-alpha-stimulating drugs. It reduces weight gain in normal mice, but fails to do so in mice lacking PPAR-alpha.

In normal situations, OEA regulates the expression of several genes that are downstream of PPAR-alpha. It initiates the production of proteins that are involved in lipid metabolism and represses an enzyme that may stimulate feeding behaviour.

CONTACT:

Daniele Piomelli
University of California, Irvine, CA, USA
Tel: +1 949 824 6180
E-mail: piomelli@uci.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.